RecruitingNot ApplicableNCT06704698

Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery

Paravertebral Block With Liposomal Bupivacaine and Epidural Block With Plane Bupivacaine for Postoperative Analgesia in Esophageal Surgery: A Randomized, Non-inferiority Study


Sponsor

Zhejiang Cancer Hospital

Enrollment

132 participants

Start Date

Dec 3, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Prevention of postoperative pain is essential for the recovery of esophageal surgery. Epidural analgesia is a traditional and standard perioperative pain management for these patients. Beneficials of epidural analgesia have been widely established. However, there are still several potential disadvantages such as perioperative hypotension, failure of administration, rare but serious neurological complications. Ultrasound-guided regional nerve block has become a widely used technique due to its low degree of trauma and precise target of action. In combined with liposome bupivacaine (LB), a new long-acting local anesthetic, was proven to have a maximum duration of 72 hours, thus improving postoperative analgesia, reducing opioid consumption, and enhancing patient satisfaction. The aim of this study was to evaluate the efficacy of TPVB liposomal bupivacaine (LB) or plane bupivacaine (SB) for Overall Benefit of Analgesic Score (OBAS) after esophageal surgery.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria3

  • American Society of Anesthesiologist physical status I-III;
  • Scheduled elective thoracoscopic esophagectomy(three-incision approach);
  • Approved participation before study.

Exclusion Criteria5

  • Patients with contraindications for local nerve block such as spinal anatomic structure abnormality or local infection of puncture area;
  • Anergic to medications used in this study;
  • Patient have chronic pain;
  • Patient receiving anticoagulants, opioids or have a history of narcotic abuse or alcohol abuse;
  • Inability to complete postoperative pain assessments or questionnaires due to communication barriers or mental disorders;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLiposomal bupivacaine

Thoracic paravertebral block with liposomal bupivacaine.

DRUGBupivacaine Hydrochloride

Epidural block with plane bupivacaine.


Locations(1)

Jiangling Wang

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06704698


Related Trials